Id
|
Protein
|
PTM type
|
Site
|
Species
|
Disease
|
Celline
|
Drug
|
Regulatory
|
Score
|
Ref.
|
acc0151 |
AKT |
phosphorylation |
Ser473 |
human |
Endometrial Cancer |
Ishikawa |
Cisplatin |
Negative |
5.0 |
18687514
|
acc0152 |
AKT |
phosphorylation |
Thr308 |
human |
Endometrial Cancer |
Ishikawa |
Perifosine |
Unresolved |
4.0 |
18687514
|
acc0153 |
AKT |
phosphorylation |
Thr308 |
human |
Endometrial Cancer |
HEC-1A |
Perifosine |
Unresolved |
4.0 |
18687514
|
acc0154 |
AKT |
phosphorylation |
Thr308 |
human |
Endometrial Cancer |
Ishikawa |
Cisplatin |
Negative |
5.0 |
18687514
|
acc0155 |
Smad3 |
phosphorylation |
Ser425 |
human |
Renal Cancer |
FU-UR-1 |
Halofuginone |
Unresolved |
4.0 |
18714394
|
acc0156 |
EphA2 |
phosphorylation |
Tyr100 |
human |
Pancreas Cancer |
BxPC-3 |
Dasatinib |
Unresolved |
4.0 |
18797457
|
acc0157 |
EphA2 |
phosphorylation |
Tyr100 |
human |
Pancreas Cancer |
PANC-1 |
Dasatinib |
Unresolved |
4.0 |
18797457
|
acc0158 |
EphA2 |
phosphorylation |
Tyr100 |
human |
Pancreas Cancer |
MIA PaCa-2 |
Dasatinib |
Unresolved |
4.0 |
18797457
|
acc0159 |
HER2 |
phosphorylation |
Tyr1221 |
human |
Breast Cancer |
|
Tamoxifen |
Negative |
5.0 |
19239686
|
acc0160 |
HER2 |
phosphorylation |
Tyr1222 |
human |
Breast Cancer |
|
Tamoxifen |
Negative |
5.0 |
19239686
|
acc0161 |
AKT |
phosphorylation |
Ser473 |
human |
Schwannoma |
RT4-D6P2T |
Phosphatidylinositols |
Negative |
5.0 |
19351837
|
acc0162 |
merlin |
phosphorylation |
Ser315 |
human |
Schwannoma |
RT4-D6P2T |
Phosphatidylinositols |
Negative |
5.0 |
19351837
|
acc0163 |
ATM |
phosphorylation |
Ser1981 |
human |
Leukemia |
|
Doxorubicin |
Unresolved |
4.0 |
19411853
|
acc0164 |
H2AX |
phosphorylation |
Ser139 |
human |
Leukemia |
|
Doxorubicin |
Unresolved |
3.0 |
19411853
|
acc0165 |
ATM |
phosphorylation |
Ser1981 |
human |
Leukemia |
|
Daunomycin |
Unresolved |
4.0 |
19411853
|
acc0166 |
H2AX |
phosphorylation |
Ser139 |
human |
Leukemia |
|
Daunomycin |
Unresolved |
3.0 |
19411853
|
acc0167 |
ATM |
phosphorylation |
Ser1981 |
human |
Leukemia |
|
Mitoxantrone |
Unresolved |
4.0 |
19411853
|
acc0168 |
H2AX |
phosphorylation |
Ser139 |
human |
Leukemia |
|
Mitoxantrone |
Unresolved |
3.0 |
19411853
|
acc0169 |
ATM |
phosphorylation |
Ser1981 |
human |
Leukemia |
|
Idarubicin |
Unresolved |
4.0 |
19411853
|
acc0170 |
H2AX |
phosphorylation |
Ser139 |
human |
Leukemia |
|
Idarubicin |
Unresolved |
3.0 |
19411853
|
acc0171 |
Src |
phosphorylation |
Tyr419 |
human |
Sarcoma |
SaOS-2 |
Dasatinib |
Unresolved |
4.0 |
19447875
|
acc0172 |
Src |
phosphorylation |
Tyr419 |
human |
Sarcoma |
143B |
Dasatinib |
Unresolved |
4.0 |
19447875
|
acc0173 |
VEGFR |
phosphorylation |
Tyr |
human |
Leukemia |
AML |
Idarubicin |
Negative |
5.0 |
19463770
|
acc0174 |
PDGFR |
phosphorylation |
Tyr751 |
human |
Sarcoma |
MPNST |
Imatinib |
Unresolved |
4.0 |
19627534
|
acc0175 |
STAT5 |
phosphorylation |
Tyr694 |
human |
Leukemia |
MV4-11 |
Cabozantinib |
Unresolved |
4.0 |
27060207
|
acc0176 |
FLT3 |
phosphorylation |
Tyr589 |
human |
Leukemia |
MV4-11 |
Cabozantinib |
Unresolved |
4.0 |
27060207
|
acc0177 |
FLT3 |
phosphorylation |
Tyr591 |
human |
Leukemia |
MV4-11 |
Cabozantinib |
Unresolved |
4.0 |
27060207
|
acc0178 |
AKT |
phosphorylation |
Ser473 |
human |
Leukemia |
MV4-11 |
Cabozantinib |
Unresolved |
4.0 |
27060207
|
acc0179 |
ERK1 |
phosphorylation |
Thr202 |
human |
Leukemia |
MV4-11 |
Cabozantinib |
Unresolved |
4.0 |
27060207
|
acc0180 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Leukemia |
MV4-11 |
Cabozantinib |
Unresolved |
4.0 |
27060207
|
acc0181 |
ERK2 |
phosphorylation |
Thr185 |
human |
Leukemia |
MV4-11 |
Cabozantinib |
Unresolved |
4.0 |
27060207
|
acc0182 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Leukemia |
MV4-11 |
Cabozantinib |
Unresolved |
4.0 |
27060207
|
acc0183 |
MAPK |
phosphorylation |
unclear |
human |
Ovarian Cancer |
A2780 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0184 |
MAPK |
phosphorylation |
unclear |
human |
Ovarian Cancer |
CAOV-3 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0185 |
AKT |
phosphorylation |
unclear |
human |
Ovarian Cancer |
SK-OV-3 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0186 |
AKT |
phosphorylation |
unclear |
human |
Ovarian Cancer |
ES-2 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0187 |
ER |
phosphorylation |
Ser118 |
human |
Ovarian Cancer |
A2780 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0188 |
ER |
phosphorylation |
Ser167 |
human |
Ovarian Cancer |
A2780 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0189 |
ER |
phosphorylation |
Ser118 |
human |
Ovarian Cancer |
CAOV-3 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0190 |
ER |
phosphorylation |
Ser167 |
human |
Ovarian Cancer |
CAOV-3 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0191 |
ER |
phosphorylation |
Ser118 |
human |
Ovarian Cancer |
SK-OV-3 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0192 |
ER |
phosphorylation |
Ser167 |
human |
Ovarian Cancer |
SK-OV-3 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0193 |
ER |
phosphorylation |
Ser118 |
human |
Ovarian Cancer |
ES-2 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0194 |
ER |
phosphorylation |
Ser167 |
human |
Ovarian Cancer |
ES-2 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0195 |
MAPK |
phosphorylation |
unclear |
human |
Ovarian Cancer |
SK-OV-3 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0196 |
MAPK |
phosphorylation |
unclear |
human |
Ovarian Cancer |
ES-2 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0197 |
AKT |
phosphorylation |
unclear |
human |
Ovarian Cancer |
A2780 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0198 |
AKT |
phosphorylation |
unclear |
human |
Ovarian Cancer |
CAOV-3 |
Tamoxifen |
Unresolved |
4.0 |
20056081
|
acc0199 |
IkB |
phosphorylation |
unclear |
human |
Prostate Cancer |
DU145 |
EC-70124 |
Unresolved |
4.0 |
26826115
|
acc0200 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
DU145 |
EC-70124 |
Unresolved |
4.0 |
26826115
|